Opioid-sparing effects of SoluMatrix indomethacin in a phase 3 study in patients with acute postoperative pain
The Clinical Journal of Pain Jan 11, 2018
Gharibo CG, et al. - In a phase 3 study in patients with acute pain following bunionectomy, researchers reported the opioid-sparing effects of SoluMatrix indomethacin, developed using SoluMatrix Fine Particle Technology. Observations revealed the opioid-sparing effects in association with SoluMatrix indomethacin in patients with acute postoperative pain.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
